Table 5.
Variable | N | Yes | No | Neutral | X2 | P-value |
---|---|---|---|---|---|---|
Total | 1043 | 597 (57.2) | 24017 | 206 (19.8) | ||
Knowledge toward COVID-19 vaccine | ||||||
Vaccination in general is an effective way to prevent and control infectious diseases | 391.42 | <.001 | ||||
Strongly agree | 240 (23.0) | 206 (85.8) | 125 | 22 (9.2) | ||
Agree | 424 (40.7) | 295 (69.6) | 59 (13.9) | 70 (16.5) | ||
Neutral | 265 (25.4) | 88 (33.2) | 79 (29.8) | 98 (37) | ||
Disagree | 67 (6.4) | 69 | 50 (74.6) | 11 (16.4) | ||
Strongly disagree | 47 (4.5) | 2 (4.3) | 40 (85.1) | 5 (10.6) | ||
Vaccination against infectious diseases reduces both the incidence of diseases and the mortality rate among individuals | 188.09 | <.001 | ||||
Strongly agree | 315 (30.2) | 238 (75.6) | 33 (10.5) | 4414 | ||
Agree | 484 (46.4) | 295 (61) | 9718 | 9219 | ||
Neutral | 174 (16.7) | 49 (28.2) | 63 (36.2) | 62 (35.6) | ||
Disagree | 51 (4.9) | 9 (17.6) | 35 (68.6) | 7 (13.7) | ||
Strongly disagree | 19 (1.8) | 6 (31.6) | 12 (63.2) | 1 (5.3) | ||
The Benefits of COVID-19 vaccine outweigh the risks | 348.28 | <.001 | ||||
Strongly agree | 144 (13.8) | 126 (87.5) | 10 (6.9) | 8 (5.6) | ||
Agree | 361 (34.6) | 269 (74.5) | 43 (11.9) | 49 (13.6) | ||
Neutral | 363 (34.8) | 171 (47.1) | 6919 | 123 (33.9) | ||
Disagree | 89 (8.5) | 18 (20.2) | 55 (61.8) | 1620 | ||
Strongly disagree | 86 (8.2) | 13 (15.1) | 63 (73.3) | 10 (11.6) | ||
The COVID-19 vaccine will generally be effective in controlling the infection | 475.297 | <.001 | ||||
Strongly agree | 162 (15.5) | 150 (92.6) | 8 (4.9) | 4 (2.5) | ||
Agree | 458 (43.9) | 341 (74.5) | 36 (7.9) | 81 (17.7) | ||
Neutral | 299 (28.7) | 96 (32.1) | 96 (32.1) | 107 (35.8) | ||
Disagree | 82 (7.9) | 10 (12.2) | 62 (75.6) | 10 (12.2) | ||
Strongly disagree | 42 (4.0) | 0 (0) | 38 (90.5) | 4 (9.5) | ||
Younger adults under 30 and children do not need to be vaccinated against COVID-19 | 199.63 | <.001 | ||||
Strongly agree | 94 (9.0) | 30 (31.9) | 52 (55.3) | 12 (12.8) | ||
Agree | 173 (16.6) | 64 (37) | 74 (42.8) | 35 (20.2) | ||
Neutral | 300 (28.8) | 140 (46.7) | 65 (21.7) | 95 (31.7) | ||
Disagree | 337 (32.3) | 252 (74.8) | 35 (10.4) | 50 (14.8) | ||
Strongly disagree | 139 (13.3) | 111 (79.9) | 14 (10.1) | 14 (10.1) | ||
Attitudes toward COVID-19 vaccine | ||||||
How safe COVID-19 vaccine in your opinion? | 481.05 | <.001 | ||||
very safe | 102 (9.8) | 93 (91.2) | 5 (4.9) | 4 (3.9) | ||
Fairly safe | 515 (49.4) | 393 (76.3) | 34 (6.6) | 88 (17.1) | ||
a little safety | 286 (27.4) | 99 (34.6) | 87 (30.4) | 100 (35) | ||
Not safe at all | 140 (13.4) | 12 (8.6) | 114 (81.4) | 1410 | ||
What are the COVID-19 vaccine effects in your opinion? | 151.11 | <.001 | ||||
It can cause COVID-19 infection | 163 (15.6) | 33 (20.2) | 95 (58.3) | 35 (21.5) | ||
It prevents COVID-19 infection | 80 (7.7) | 53 (66.3) | 1215 | 15 (18.8) | ||
They reduce the symptoms and severity of COVID-19 infection | 800 (76.7) | 511 (63.9) | 133 (16.6) | 156 (19.5) | ||
How easy do you think it is to get the COVID-19 vaccine? | 125.07 | <.001 | ||||
very easy | 290 (27.8) | 212 (73.1) | 49 (16.9) | 2910 | ||
fairly easy | 474 (45.4) | 289 (61) | 84 (17.7) | 101 (21.3) | ||
I’m not sure | 145 (13.9) | 37 (25.5) | 69 (47.6) | 39 (26.9) | ||
Somewhat difficult | 116 (11.1) | 54 (46.6) | 28 (24.1) | 34 (29.3) | ||
very Difficult | 18 (1.7) | 5 (27.8) | 10 (55.6) | 3 (16.7) | ||
COVID-19 Vaccines are available in Libya | 122.42 | <.001 | ||||
Strongly agree | 142 (13.6) | 111 (78.2) | 1712 | 14 (9.9) | ||
Agree | 511 (49.0) | 335 (65.6) | 91 (17.8) | 85 (16.6) | ||
Neutral | 274 (26.3) | 103 (37.6) | 83 (30.3) | 88 (32.1) | ||
Disagree | 85 (8.1) | 40 (47.1) | 29 (34.1) | 16 (18.8) | ||
Strongly disagree | 31 (3.0) | 8 (25.8) | 20 (64.5) | 3 (9.7) | ||
Concerns about COVID-19 Vaccine? | 232.69 | <.001 | ||||
Against vaccines in general | 23 (2.2) | 5 (21.7) | 14 (60.9) | 4 (17.4) | ||
I don’t trust the medical health system | 182 (17.4) | 65 (35.7) | 69 (37.9) | 48 (26.4) | ||
The COVID-19 is virus not dangerous | 18 (1.7) | 9 (50) | 7 (38.9) | 2 (11.1) | ||
It has not been adequately researched or tested | 1 (0.1) | 0 | 1 (100) | 0 | ||
Lack of information | 157 (15.1) | 101 (64.3) | 24 (15.3) | 32 (20.4) | ||
Side effects | 274 (26.3) | 166 (60.6) | 53 (19.3) | 55 (20.1) | ||
Unsafe | 44 (4.2) | 5 (11.4) | 29 (65.9) | 10 (22.7) | ||
not effective | 14 (1.3) | 4 (28.6) | 4 (28.6) | 6 (42.9) | ||
Fear of injection | 29 (2.8) | 18 (62.1) | 6 (20.7) | 5 (17.2) | ||
Cultural reasons | 22 (2.1) | 8 (36.4) | 7 (31.8) | 7 (31.8) | ||
safe with traditional remedies | 101 | 4 (40) | 4 (40) | 218 | ||
Other | 525 | 20 (38.5) | 12 (23.1) | 20 (38.5) | ||
I have no worries | 217 (20.8) | 192 (88.5) | 10 (4.6) | 15 (6.9) |
A p-value of less than .05 indicates statistical significance. Abbreviations. X2: Chi-square test.